• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

DOJ scraps di­vi­sive Chi­na Ini­tia­tive that swept up promi­nent sci­en­tists — but vows to keep guard­ing against ...

4 years ago
People
China

'F--- the fed­s': Mar­tin Shkre­li barred from run­ning all pub­lic com­pa­nies as judge de­cries re­morse­less be­hav­ior

4 years ago
Pharma

Till­man Gern­gross makes it of­fi­cial: He's out as CEO as trou­bled Ada­gio vows to sol­dier on

4 years ago
People
R&D

With a new start­up, ARCH and Take­da wade in­to grow­ing search for a Swiss Army knife RNA drug

4 years ago
Financing
Startups

Uniden­ti­fied wit­ness­es ac­cuse Bris­tol My­ers of scut­tling time­ly FDA move on liso-cel to avoid $6.4B pay­out

4 years ago
Pharma

Spec­trum's pen­ny stock takes an­oth­er hit as CFO qui­et­ly plans ex­it

4 years ago
People
Pharma

Mod­er­na ties the knot with Ther­mo Fish­er on a 15-year man­u­fac­tur­ing al­liance, glu­ing a glob­al net­work

4 years ago
Manufacturing

Build­ing on CRISPR suc­cess, In­tel­lia inks deal for new man­u­fac­tur­ing fa­cil­i­ty in Waltham, MA

4 years ago
Pharma
Cell/Gene Tx

Ake­bia scrapes to­geth­er $85M war chest to com­mer­cial­ize va­da as PDU­FA date looms

4 years ago
Financing
Pharma

Ab­b­Vie sees a megablock­buster in Vray­lar. Could a new de­pres­sion in­di­ca­tion push peak sales past $4B?

4 years ago
Pharma

Phar­ma sus­tain­abil­i­ty: Am­gen de­buts $750M ‘green bond,’ Mer­ck ini­ti­ates ESG goal re­view

4 years ago
Pharma
Marketing

FDA+ roundup: As­ses­sor finds FDA's new biosim­i­lar re­view mod­el makes the process more pre­dictable

4 years ago
FDA+

Bay­er on­col­o­gy vet Robert La­Caze has his eyes on next steps — land­ing his first gig as CEO of Sade­lain co-found­ed ...

4 years ago
People
R&D

With Spark safe­ly tucked in­to Roche, its found­ing CEO is off to search for new ad­ven­tures

4 years ago
People
Cell/Gene Tx

Man­u­fac­tur­ing re­org at Mer­ck KGaA in­spires a $500M+ in­vest­ment in mR­NA tech

4 years ago
Pharma
Manufacturing

Kiniksa inks li­cens­ing deal to take a Re­gen­eron castoff in­to Asian mar­kets

4 years ago
Deals

mR­NA for all: WHO es­tab­lish­es bio­man­u­fac­tur­ing train­ing hub in Ko­rea

4 years ago
Coronavirus
Manufacturing

Soft­Bank, RA keep pump­ing mon­ey in­to biotech star­tups as pro­tein degra­da­tion play­er bags $102M

4 years ago
Financing

Sanofi, GSK prep reg­u­la­to­ry fil­ings for Covid-19 vac­cine af­ter post­ing PhI­II, boost­er da­ta — but who will use it?

4 years ago
R&D
Coronavirus

Ko­di­ak’s Eylea con­tender falls flat in PhI­II, wip­ing out near­ly $2B in val­ue

4 years ago
R&D

Covid-19 roundup: Africa CDC to seek vac­cine do­na­tion pause — re­port; New study sug­gests blood clots from ...

4 years ago
Coronavirus

Al­most 9 in 10 Amer­i­cans want the FDA to ex­plain why some drugs are re­ject­ed, new JA­MA sur­vey finds

4 years ago
FDA+

They made the first an­ti-VEGF drug 20+ years ago. Now two long­time part­ners have $65M to spot new eye drugs

4 years ago
Financing
Startups

As­traZeneca's Pas­cal So­ri­ot brought home near­ly $19M last year, dwarf­ing some of Eu­rope's high­est phar­ma pay pack­ages

4 years ago
Pharma
First page Previous page 569570571572573574575 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times